There is a version of skincare where anti-aging means retinoids, and retinoids mean redness, peeling, and a two-month adjustment period that tests your commitment to the cause. Then there is Matrixyl. No adjustment period. No irritation. No purging. No pregnancy restrictions. Just peptides, quietly doing their work beneath a layer of moisturizer while you go about your life entirely unbothered.
The Ordinary's Matrixyl 10% + HA has been part of the brand's lineup since its 2016 launch, and in many ways it embodies the DECIEM thesis more purely than any other product in the range. Matrixyl — a trade name developed by Sederma, the French cosmetic ingredient company now owned by BASF — had been a prestige ingredient for years, licensed to brands that sold peptide serums for 0, 20, sometimes 00. The Ordinary put it in a 0.90 bottle at 10% concentration and let the ingredient speak for itself.
The formula contains two Matrixyl generations. Matrixyl 3000 combines Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7 — two peptides that work on opposite sides of the collagen equation. Tripeptide-1 is a matrikine, a signaling peptide that tells fibroblasts to produce new collagen as if they were repairing micro-damage. Tetrapeptide-7 reduces interleukin-6 secretion, an inflammatory cytokine that drives collagen degradation. One peptide pushes production up. The other pushes breakdown down. The combination, in manufacturer-funded clinical trials, reduced wrinkle area by 44% and wrinkle density by 37% over two months of twice-daily application.
Matrixyl Synthe'6, the second generation, goes broader. Palmitoyl Tripeptide-38 signals the production of six different extracellular matrix components simultaneously: collagen I, III, and IV, fibronectin, hyaluronic acid, and laminin 5. This is not just collagen stimulation — it is a comprehensive matrix repair signal. The skin's structural integrity depends on the interplay between all these components, and Synthe'6 addresses the scaffold as a system rather than targeting one protein in isolation.
The 10% concentration is worth appreciating in context. Many peptide serums list Matrixyl or its components on their INCI but at concentrations well below the levels used in clinical studies. At 10% of the total formula by weight, The Ordinary is delivering a genuinely generous dose. The peptides are dissolved in an aqueous base of glycerin and sodium hyaluronate, which provides immediate surface hydration and helps stabilize the peptides in a skin-compatible pH range of 5.0-6.0.
On the skin, this serum applies as a clear, slightly viscous liquid with a faint tackiness from the hyaluronic acid. It is not unpleasant, but if you have strong preferences about serum texture, you will notice it for the first two to three minutes before it absorbs. Once a moisturizer goes on top, the tackiness vanishes completely. There is no tingling, no warmth, no sensation at all — which is exactly what a peptide serum should feel like. Peptides work through cellular signaling, not through the kind of chemical activity that produces sensory feedback.
The timeline for results is where expectations need careful calibration. Peptides do not work like retinoids. There is no dramatic peeling phase followed by revealed baby-smooth skin. There is no purging period where things look worse before they look better. Instead, there is a slow, incremental improvement that builds over weeks and months. By week four, skin may feel slightly firmer and more hydrated — partly from the HA, partly from the early effects of increased collagen synthesis. By week eight to twelve, fine lines around the eyes and forehead begin to soften in a way that is easier to measure than to perceive in the mirror. By month three to six, the cumulative improvement becomes genuinely visible, particularly in before-and-after photographs.
This gradual nature is both the product's strength and its PR problem. Plenty of users have posted reviews saying some variation of "I used it for a month and I am not sure it did anything." Peptide results are not designed to be dramatic — they are designed to be sustainable. The collagen you build with consistent peptide use accumulates over time, and the anti-inflammatory effects of Tetrapeptide-7 help preserve what you build. It is investment-grade skincare: unglamorous in the short term, genuinely valuable over years.
The pregnancy-safe profile is a significant practical advantage. Retinoids — the other major category of collagen-stimulating actives — are contraindicated during pregnancy and breastfeeding. Matrixyl peptides carry no such restriction. For anyone who is pregnant, trying to conceive, or breastfeeding and wants to maintain an anti-aging routine, this product fills a gap that very few others can.
The conflict list is the main practical limitation. Peptides are hydrolyzed by low-pH environments, which means Matrixyl cannot be used in the same routine as glycolic acid, salicylic acid, L-ascorbic acid, or other direct acids. If your anti-aging strategy relies on vitamin C in the morning, you will need to use Matrixyl at night — or choose a vitamin C derivative that operates at a higher pH. For routines that already include retinoids and acids, fitting Matrixyl in requires some scheduling.
At $10.90 for a 30 mL bottle that lasts two to three months with twice-daily use, the annual cost of Matrixyl therapy is approximately 4-66. For context, department store peptide serums with lower Matrixyl concentrations regularly sell for 0-150 per bottle. The math is not subtle, and it is one of the most compelling arguments for The Ordinary's approach to skincare: that premium ingredients, at generous concentrations, do not require premium pricing.
